CEP/DRP Awardees: 2018
| Award | Name | Affiliation | Project Title |
|---|---|---|---|
| CEP | Patrick Cahan | Associate Professor, Dept of Biomedical Engineering, School of Medicine, JHU | Using gene regulatory networks to map cancer models to human tumors |
| CEP | Stephanie Wethington | Assistant Professor, Dept of Gynecologi/Obstetrics, School of Medicine, JHU | Combination ATR and PARP Inhibitor (CAPRI) trial: AZD6738 and Olaparib in recurrent ovarian cancer |
| DRP | Ravi Anchoori | Research Associate, Dept of Pathology, School of Medicine, JHU | Inhibition of RPN13 as a novel treatment option for BRCA deficient ovarian tumors |
CEP/DRP Awardees: 2019
| Award | Name | Affiliation | Project Title |
|---|---|---|---|
| CEP | Stephanie Gaillard | Assistant Professor, Dept of Oncology, School of Medicine, JHU | Combination of radiation and PARP inhibition for treatment of ARID1A deficient ovarian cancer: Pilot feasibility study |
| CEP | Anthony KL Leung | Associate Professor, Dept of Biochemistry and Molecular Biology, Bloomberg School of Public Health, JHU | Explore PARP1 PARylation signatures as a biomarker of PARP inhibitor sensitivity |
| CEP | Sudipto Ganguly | Assistant Professor, Dept of Oncology, School of Medicine, JHU | Targeting the PVRIG-PVRL2 checkpoint axis in high-grade serous carcinoma |
| CEP | Lainie P. Martin | Associate Professor, Dept of Medicine at the Hospital of the University of Pennsylvania | Combination of a BET inhibitor and carboplatin in HGSC |
| DRP | Cynthia Zahnow | Associate Professor, Dept of Oncology, School of Medicine, JHU | Regulation of the M1/M2 macrophage ratio in ovarian cancer |
CEP/DRP Awardees: 2020
| Award | Name | Affiliation | Project Title |
|---|---|---|---|
| CEP | Yun Chen | Assistant Professor, Dept of Mechanical Engineering, Whiting School of Medicine, JHU | Bioengineering of metastatic ovarian cancer in omental microenvironment |
| CEP | Shigehiro Yamada | Research Associate, Dept of Gynecology/Obstetrics, School of Medicine, JHU | Studying Fallopaint Tube and Endometrium Early Pathogenesis |
| DRP | Alan D. Friedman | Professor, Dept of Oncology, School of Medicine, JHU | Mesothelin-Targeted Activated Myeloid Cells as a Novel Immunotherapy for Ovarian Cancer |
| DRP | Kathy Gabrielson | Associate Professor, Dept of Molecular and Comparative Biology, School of Medicine, JHU | Role of prenatal stress on ovarian cancer initiation and progression |
| DRP | Ravi Anchoori | Research Associate, Dept of Oncology, School of Medicine, JHU | Inhibition of RPN13 as a novel treatment option for BRCA deficient ovarian tumors |
| DRP | Andrea Facciabene | Research Associate Professor, Dept of Radiation Oncology, University of Pennsylvania | To identify the ovarian cancer metabolome linked with BRCA patients’ gut microbial signature |
| DRP | Nawar Latif | Assistant Professor, Dept of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania | Feasibility study of pre-operative prediction of suboptimal cytoreduction in advanced ovarian cancer through artificial intelligence |